During the past decade, Downtown L.A. Research Center, Inc conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Downtown L.A. Research Center, Inc" #1 sponsor was "Kowa Research Institute, Inc." with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored, "Verona Pharma plc" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Downtown L.A. Research Center, Inc" #1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator and "Nova Clinical Solutions, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Downtown L.A. Research Center, Inc" are "Chronic Obstructive Pulmonary Disease" (2 trials), "Influenza" (2 trials), "Overactive Bladder" (2 trials), "Severe Hypertriglyceridemia" (2 trials) and "Acute Migraine" (1 trials). Many other conditions were trialed in "Downtown L.A. Research Center, Inc" in a lesser frequency.

Most popular intervention types in "Downtown L.A. Research Center, Inc" are "Drug" (16 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ensifentrine" (2 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Downtown L.A. Research Center, Inc" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Downtown L.A. Research Center, Inc". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Downtown L.A. Research Center, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Downtown L.A. Research Center, Inc, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".